Abstract
Background and Aims : It has been reported that P-selectin, a marker of platelet activation, is associated with denser fibrin networks in coronary artery disease (CAD). It is unclear whether high-intensity statin therapy reduces P-selectin levels and such changes can affect the fibrin clot phenotype in CAD patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
